Jennifer P. King

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 455 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16

Risk of anaphylaxis after vaccination in children and adults

Michael M. McNeil, Eric Weintraub, Jonathan Duffy et al. · Journal of Allergy and Clinical Immunology · 2015 · 387 citations · Full text

Life Sciences, Immunology, Pediatrics +10

Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season

Melissa A. Rolfes, Brendan Flannery, Jessie R. Chung et al. · Clinical Infectious Diseases · 2019 · 305 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

Mark W. Tenforde, Wesley H. Self, Eric A. Naioti et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 246 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old

Edward A. Belongia, Jennifer P. King, Burney A. Kieke et al. · Open Forum Infectious Diseases · 2018 · 158 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17